AzTrials
AzTrials

Pregnant WomenNCT07356180

Physical Acvitiy in Pregnancy

An observational study of Pregnant Women and Gestational Diabetes, run by University of Maryland, Baltimore at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to learn how a physically active lifestyle during pregnancy affects placental development and function. The main question it aims to answer is: Does regular physical activity during pregnancy improve placental function and support healthy fetal growth? Pregnant participants will… Read more about this study

Who is it for?
Ages 18 to 45 years, women only
What is being tested?
Pregnancy Physical Activity Questionnaire (PPAQ)
How many people
40 participants
Where
1 siteUnited States
Study dates
18 Oct 2023to Dec 2027
How long will I take part?
2 Days
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: The study population consists of pregnant individuals receiving prenatal care and/or delivering at affiliated clinical sites of the University of Maryland, Baltimore and surrounding community healthcare settings. Participants will be recruited from local obstetric clinics and hospital-based prenatal care programs. The study represents a community-based sample of pregnant individuals with varying levels of physical activity during pregnancy.

Who may be able to join

  • Pregnant female and their newborn infant(s)
  • Aged 18-45 (pregnant female), age 0-60 days of life (newborn infant)
  • English speaking
  • Screened for gestational diabetes with standard glucose tolerance test between 24w - 41w gestation
  • Delivered at gestational age 34week-41weeks
  • Delivered via non-emergent Cesarean section during weekday hours
  • No known infectious disease (ex: HIV, HepC)

Who cannot join

  • Women <18yo or >45yo
  • Non-English speaking
  • Pre-existing diabetes or diagnosed with diabetes prior to 24weeks
  • Required complex diets/supplements not related to the pregnancy (i.e. malnutrition)
  • Known severe fetal anomalies or genetic disorder
  • Placenta accreta spectrum
  • Emergent cesarean delivery performed due to fetal distress
  • Known infectious disease (ex: HIV, HepC)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • University of Maryland Medical System

    Baltimore, Maryland, 21201

Other trials in United States

About this study

Official title: Epigenetic Regulation of Physically Active Lifestyle on Placental Development

The goal of this observational study is to learn how a physically active lifestyle during pregnancy affects placental development and function. The main question it aims to answer is:

Does regular physical activity during pregnancy improve placental function and support healthy fetal growth?

Pregnant participants will provide biological samples and health information during pregnancy and at delivery. The study will use these samples to examine how activity levels relate to placental energy production and overall health.

Read the detailed description

This observational study aims to examine how a physically active lifestyle during pregnancy affects placental function and fetal development. We will enroll pregnant participants and collect biological samples, including blood and placental tissue after delivery. The study will measure markers of placental energy production and other indicators of placental health to understand the mechanisms by which maternal physical activity may influence fetal growth.

Data collected will also include health information, lifestyle questionnaires, and activity assessments during pregnancy. Participants will not need to change their normal exercise habits. The results of this study may help identify how maternal physical activity supports placental and fetal health, which could inform future recommendations for healthy pregnancies.

Being tested
Pregnancy Physical Activity Questionnaire (PPAQ)
Keywords
maternal exercise, gestational diabetes, maternal physical activity, pregnancy, placental function, fetal development, maternal obesity, observational study, placental mitochondria, lifestyle intervention, pregnancy outcomes
Medical subject headings
Diabetes, Gestational, Overweight, Pregnancy in Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pregnancy Physical Activity Questionnaire (PPAQ)Behavioural

    The PPAQ is a semiquantitative questionnaire that asks respondents to report the time spent participating in 32 activities including household/caregiving (13 activities),occupational (5 activities), sports/exercise (8 activities), transportation (3 activities), and inactivity (3 activities).

    For each activity, respondents are asked to select the category that best approximates the amount of time spent in that activity per day or week during the currenttrimester. Possible durations range from 0 to 6 or more hours per day and from 0 to 3 or more hours per week.

Study groups in NCT07356180
Study groupRoleWhat they receive
Conpre-pregnancy BMI 18.5-24.9, no gestational diabetes
Receives: Behavioral: Pregnancy Physical Activity Questionnaire (PPAQ)
overweight/obesity grouppre-pregnancy BMI of 25 or greater, no gestational diabetes
Receives: Behavioral: Pregnancy Physical Activity Questionnaire (PPAQ)
Gestational DM grouppre-pregnancy BMI 18.5-24.9 with gestational diabetes
Receives: Behavioral: Pregnancy Physical Activity Questionnaire (PPAQ)
gestational DM + overweight/obesity grouppre-pregnancy BMI of 25 or greater, with gestational diabetes
Receives: Behavioral: Pregnancy Physical Activity Questionnaire (PPAQ)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Placental mitochondrial function

    Placental mitochondrial function will be assessed using markers of mitochondrial biogenesis and energy metabolism measured in placental tissue collected at delivery. Outcomes will be examined in relation to maternal physical activity levels during pregnancy.

    Measured: At delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jan 2026
  2. Study start18 Oct 2023
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
40 participants (estimated)
Target duration
2 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT07356180
Sponsor's protocol ID
HP-00099879
Status last verified
Dec 2025
First submitted
12 Jan 2026
Last updated
21 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Results of our study will not be shared with the subjects. We plan on publishing our results in a peer reviewed journal. We also plan to present the results as a thesis dissertation for Dr. Esteves. We also hope the results will generate evidence for benefits of physical activity during pregnancy, which will lead to seeking extramural NIH grants for cohort study of pregnant women with exercise programs.

Questions about this trial

What is this clinical trial studying?

An observational study of Pregnant Women and Gestational Diabetes, run by University of Maryland, Baltimore at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 21 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Placental mitochondrial function (time frame: At delivery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in